Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase, transcript variant c |
FXC00077
|
FHC00077
|
FNC00077N
|
FNC00077C
|
BRCA1 |
breast cancer 1, early onset, transcript variant 1 |
FXC00344
|
FHC00344
|
FNC00344N
|
FNC00344C
|
HERC3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant 1 |
FXC00376
|
FHC00376
|
FNC00376N
|
FNC00376C
|
CUL7 |
cullin 7, transcript variant 2 |
FXC00397
|
FHC00397
|
FNC00397N
|
FNC00397C
|
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase, transcript variant 1 |
FXC00406
|
FHC00406
|
FNC00406N
|
FNC00406C
|
UBE4A |
ubiquitination factor E4A, transcript variant 1 |
FXC00418
|
FHC00418
|
FNC00418N
|
FNC00418C
|
KEAP1 |
kelch-like ECH-associated protein 1, transcript variant 2 |
FXC00420
|
FHC00420
|
FNC00420N
|
FNC00420C
|
MGRN1 |
mahogunin ring finger 1, E3 ubiquitin protein ligase, transcript variant 3 |
FXC00557
|
FHC00557
|
FNC00557N
|
FNC00557C
|
CUL3 |
cullin 3, transcript variant 1 |
FXC00577
|
FHC00577
|
FNC00577N
|
FNC00577C
|
UBOX5 |
U-box domain containing 5, transcript variant 1 |
FXC00663
|
FHC00663
|
FNC00663N
|
FNC00663C
|
FZR1 |
fizzy/cell division cycle 20 related 1, transcript variant 2 |
FXC00776
|
FHC00776
|
FNC00776N
|
FNC00776C
|
SYVN1 |
synovial apoptosis inhibitor 1, synoviolin |
FXC00924
|
FHC00924
|
FNC00924N
|
FNC00924C
|
UBE3C |
ubiquitin protein ligase E3C |
FXC01048
|
FHC01048
|
FNC01048N
|
FNC01048C
|
DDB1 |
damage-specific DNA binding protein 1, 127kDa |
FXC01197
|
FHC01197
|
FNC01197N
|
FNC01197C
|
MID1 |
midline 1, transcript variant 5 |
FXC01257
|
FHC01257
|
FNC01257N
|
FNC01257C
|
CDC27 |
cell division cycle 27, transcript variant 2 |
FXC01271
|
FHC01271
|
FNC01271N
|
FNC01271C
|
UBA1 |
ubiquitin-like modifier activating enzyme 1, transcript variant 1 |
FXC01370
|
FHC01370
|
FNC01370N
|
FNC01370C
|
PML |
promyelocytic leukemia |
FXC01397
|
FHC01397
|
FNC01397N
|
FNC01397C
|
SAE1 |
SUMO1 activating enzyme subunit 1, transcript variant 1 |
FXC01511
|
FHC01511
|
FNC01511N
|
FNC01511C
|
TRAF6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase, transcript variant 2 |
FXC01545
|
FHC01545
|
FNC01545N
|
FNC01545C
|
UBE2O |
ubiquitin-conjugating enzyme E2O |
FXC01635
|
FHC01635
|
FNC01635N
|
FNC01635C
|
UBR5 |
ubiquitin protein ligase E3 component n-recognin 5, transcript variant 2 |
FXC01677
|
FHC01677
|
FNC01677N
|
FNC01677C
|
SKP2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase, transcript variant 1 |
FXC01758
|
FHC01758
|
FNC01758N
|
FNC01758C
|
SKP1 |
S-phase kinase-associated protein 1, transcript variant 2 |
FXC01803
|
FHC01803
|
FNC01803N
|
FNC01803C
|
ANAPC1 |
anaphase promoting complex subunit 1 |
FXC01858
|
FHC01858
|
FNC01858N
|
FNC01858C
|
TCEB1 |
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C), transcript variant 1 |
FXC02484
|
FHC02484
|
FNC02484N
|
FNC02484C
|
UBE2N |
ubiquitin-conjugating enzyme E2N |
FXC02586
|
FHC02586
|
FNC02586N
|
FNC02586C
|
UBA6 |
ubiquitin-like modifier activating enzyme 6 |
FXC02826
|
FHC02826
|
FNC02826N
|
FNC02826C
|
UBA3 |
ubiquitin-like modifier activating enzyme 3, transcript variant 1 |
FXC02921
|
FHC02921
|
FNC02921N
|
FNC02921C
|
PPIL2 |
peptidylprolyl isomerase (cyclophilin)-like 2, transcript variant 1 |
FXC02965
|
FHC02965
|
FNC02965N
|
FNC02965C
|
SOCS1 |
suppressor of cytokine signaling 1 |
FXC03002
|
FHC03002
|
FNC03002N
|
FNC03002C
|
SOCS3 |
suppressor of cytokine signaling 3 |
FXC03005
|
FHC03005
|
FNC03005N
|
FNC03005C
|
TRIM32 |
tripartite motif containing 32, transcript variant 1 |
FXC03381
|
FHC03381
|
FNC03381N
|
FNC03381C
|
PRPF19 |
pre-mRNA processing factor 19 |
FXC03437
|
FHC03437
|
FNC03437N
|
FNC03437C
|
PIAS2 |
protein inhibitor of activated STAT, 2, transcript variant beta |
FXC03457
|
FHC03457
|
FNC03457N
|
FNC03457C
|
DDB2 |
damage-specific DNA binding protein 2, 48kDa |
FXC03518
|
FHC03518
|
FNC03518N
|
FNC03518C
|
UBE2K |
ubiquitin-conjugating enzyme E2K, transcript variant 1 |
FXC03669
|
FHC03669
|
FNC03669N
|
FNC03669C
|
ERCC8 |
excision repair cross-complementation group 8, transcript variant 1 |
FXC03680
|
FHC03680
|
FNC03680N
|
FNC03680C
|
PARK2 |
parkin RBR E3 ubiquitin protein ligase, transcript variant 1 |
FXC03885
|
FHC03885
|
FNC03885N
|
FNC03885C
|
VHL |
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase, transcript variant 1 |
FXC03983
|
FHC03983
|
FNC03983N
|
FNC03983C
|
WWP1 |
WW domain containing E3 ubiquitin protein ligase 1 |
FXC04399
|
FHC04399
|
FNC04399N
|
FNC04399C
|
CUL1 |
cullin 1 |
FXC04681
|
FHC04681
|
FNC04681N
|
FNC04681C
|
FBXO2 |
F-box protein 2 |
FXC04998
|
FHC04998
|
FNC04998N
|
FNC04998C
|
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase, transcript variant 2 |
FXC05007
|
FHC05007
|
FNC05007N
|
FNC05007C
|
PIAS4 |
protein inhibitor of activated STAT, 4 |
FXC06356
|
FHC06356
|
FNC06356N
|
FNC06356C
|
RBX1 |
ring-box 1, E3 ubiquitin protein ligase |
FXC06613
|
FHC06613
|
FNC06613N
|
FNC06613C
|
TRIM37 |
tripartite motif containing 37, transcript variant 1 |
FXC07202
|
FHC07202
|
FNC07202N
|
FNC07202C
|
TRIP12 |
thyroid hormone receptor interactor 12, transcript variant 3 |
FXC07212
|
FHC07212
|
FNC07212N
|
FNC07212C
|
UBE2J1 |
ubiquitin-conjugating enzyme E2, J1 |
FXC07265
|
FHC07265
|
FNC07265N
|
FNC07265C
|
UBE2L3 |
ubiquitin-conjugating enzyme E2L 3, transcript variant 1 |
FXC07267
|
FHC07267
|
FNC07267N
|
FNC07267C
|
ANAPC10 |
anaphase promoting complex subunit 10, transcript variant 2 |
FXC07460
|
FHC07460
|
FNC07460N
|
FNC07460C
|
UBE2B |
ubiquitin-conjugating enzyme E2B |
FXC08257
|
FHC08257
|
FNC08257N
|
FNC08257C
|
WWP2 |
WW domain containing E3 ubiquitin protein ligase 2, transcript variant 1 |
FXC08703
|
FHC08703
|
FNC08703N
|
FNC08703C
|
CDC23 |
cell division cycle 23 |
FXC08907
|
FHC08907
|
FNC08907N
|
FNC08907C
|
UBE2U |
ubiquitin-conjugating enzyme E2U (putative) |
FXC09315
|
FHC09315
|
FNC09315N
|
FNC09315C
|
XIAP |
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase, transcript variant 1 |
FXC09452
|
FHC09452
|
FNC09452N
|
FNC09452C
|
SIAH1 |
siah E3 ubiquitin protein ligase 1, transcript variant 1 |
FXC09572
|
FHC09572
|
FNC09572N
|
FNC09572C
|
CDC20 |
cell division cycle 20 |
FXC09751
|
FHC09751
|
FNC09751N
|
FNC09751C
|
STUB1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase, transcript variant 1 |
FXC09916
|
FHC09916
|
FNC09916N
|
FNC09916C
|
UBE2A |
ubiquitin-conjugating enzyme E2A, transcript variant 1 |
FXC09960
|
FHC09960
|
FNC09960N
|
FNC09960C
|
UBE2C |
ubiquitin-conjugating enzyme E2C, transcript variant 1 |
FXC10067
|
FHC10067
|
FNC10067N
|
FNC10067C
|
PIAS3 |
protein inhibitor of activated STAT, 3 |
FXC10252
|
FHC10252
|
FNC10252N
|
FNC10252C
|
UBE2L6 |
ubiquitin-conjugating enzyme E2L 6, transcript variant 1 |
FXC10288
|
FHC10288
|
FNC10288N
|
FNC10288C
|
ANAPC2 |
anaphase promoting complex subunit 2 |
FXC10289
|
FHC10289
|
FNC10289N
|
FNC10289C
|
RCHY1 |
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase, transcript variant 1 |
FXC10521
|
FHC10521
|
FNC10521N
|
FNC10521C
|
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase, transcript variant 1 |
FXC10775
|
FHC10775
|
FNC10775N
|
FNC10775C
|
CDC16 |
cell division cycle 16, transcript variant 1 |
FXC10960
|
FHC10960
|
FNC10960N
|
FNC10960C
|
ITCH |
itchy E3 ubiquitin protein ligase, transcript variant 2 |
FXC11019
|
FHC11019
|
FNC11019N
|
FNC11019C
|
UBA7 |
ubiquitin-like modifier activating enzyme 7 |
FXC11051
|
FHC11051
|
FNC11051N
|
FNC11051C
|
UBE2I |
ubiquitin-conjugating enzyme E2I, transcript variant 1 |
FXC11080
|
FHC11080
|
FNC11080N
|
FNC11080C
|
ANAPC5 |
anaphase promoting complex subunit 5, transcript variant 1 |
FXC11084
|
FHC11084
|
FNC11084N
|
FNC11084C
|
UBE4B |
ubiquitination factor E4B, transcript variant 2 |
FXC11085
|
FHC11085
|
FNC11085N
|
FNC11085C
|
FBXO4 |
F-box protein 4, transcript variant 1 |
FXC11158
|
FHC11158
|
FNC11158N
|
FNC11158C
|
HERC4 |
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant 1 |
FXC11443
|
FHC11443
|
FNC11443N
|
FNC11443C
|
SCARA3 |
scavenger receptor class A, member 3, transcript variant 1 |
FXC11923
|
FHC11923
|
FNC11923N
|
FNC11923C
|
ANAPC7 |
anaphase promoting complex subunit 7, transcript variant 1 |
FXC12559
|
FHC12559
|
FNC12559N
|
FNC12559C
|
UBE3A |
ubiquitin protein ligase E3A, transcript variant 2 |
FXC12587
|
FHC12587
|
FNC12587N
|
FNC12587C
|
UBE3B |
ubiquitin protein ligase E3B, transcript variant 1 |
FXC12644
|
FHC12644
|
FNC12644N
|
FNC12644C
|
CBL |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
FXC12662
|
FHC12662
|
FNC12662N
|
FNC12662C
|
UBE2J2 |
ubiquitin-conjugating enzyme E2, J2, transcript variant 2 |
FXC20012
|
FHC20012
|
FNC20012N
|
FNC20012C
|
UBE2Q1 |
ubiquitin-conjugating enzyme E2Q family member 1 |
FXC20590
|
FHC20590
|
FNC20590N
|
FNC20590C
|
FANCL |
Fanconi anemia, complementation group L, transcript variant 2 |
FXC21013
|
FHC21013
|
FNC21013N
|
FNC21013C
|
UBE2F |
ubiquitin-conjugating enzyme E2F (putative), transcript variant 1 |
FXC21393
|
FHC21393
|
FNC21393N
|
FNC21393C
|
ANAPC13 |
anaphase promoting complex subunit 13, transcript variant 2 |
FXC21699
|
FHC21699
|
FNC21699N
|
FNC21699C
|
NHLRC1 |
NHL repeat containing E3 ubiquitin protein ligase 1 |
FXC22455
|
FHC22455
|
FNC22455N
|
FNC22455C
|
UBE2H |
ubiquitin-conjugating enzyme E2H, transcript variant 1 |
FXC23082
|
FHC23082
|
FNC23082N
|
FNC23082C
|
CDC26 |
cell division cycle 26 |
FXC23609
|
FHC23609
|
FNC23609N
|
FNC23609C
|
CUL2 |
cullin 2, transcript variant 3 |
FXC23816
|
FHC23816
|
FNC23816N
|
FNC23816C
|
FBXW8 |
F-box and WD repeat domain containing 8, transcript variant 2 |
FXC24900
|
FHC24900
|
FNC24900N
|
FNC24900C
|
UBE2Z |
ubiquitin-conjugating enzyme E2Z |
FXC26094
|
FHC26094
|
FNC26094N
|
FNC26094C
|
ANAPC11 |
anaphase promoting complex subunit 11, transcript variant 1 |
FXC26221
|
FHC26221
|
FNC26221N
|
FNC26221C
|
UBE2M |
ubiquitin-conjugating enzyme E2M |
FXC26851
|
FHC26851
|
FNC26851N
|
FNC26851C
|
UBE2G2 |
ubiquitin-conjugating enzyme E2G 2, transcript variant 1 |
FXC27206
|
FHC27206
|
FNC27206N
|
FNC27206C
|
RFWD2 |
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase, transcript variant 1 |
FXC27734
|
FHC27734
|
FNC27734N
|
FNC27734C
|
CUL5 |
cullin 5 |
FXC28065
|
FHC28065
|
FNC28065N
|
FNC28065C
|
TCEB2 |
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B), transcript variant 2 |
FXC28356
|
FHC28356
|
FNC28356N
|
FNC28356C
|
UBE2G1 |
ubiquitin-conjugating enzyme E2G 1 |
FXC28418
|
FHC28418
|
FNC28418N
|
FNC28418C
|
UBE2S |
ubiquitin-conjugating enzyme E2S |
FXC28671
|
FHC28671
|
FNC28671N
|
FNC28671C
|
PIAS1 |
protein inhibitor of activated STAT, 1 |
FXC30625
|
FHC30625
|
FNC30625N
|
FNC30625C
|
UBE2W |
ubiquitin-conjugating enzyme E2W (putative) |
FXC31238
|
FHC31238
|
FNC31238N
|
FNC31238C
|